LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

LLY

914.51

+0.93%↑

UNH

577.15

-0.55%↓

NVO

134.78

+2.03%↑

JNJ

164.87

-0.88%↓

ABBV

193.46

+0.25%↑

Accueil・Liste d'Actions・Avanos Medical Inc

Avanos Medical Inc

Fermé

Secteur Soins de santé

24.64 1.78

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

24.33

Max

24.68

Chiffres clés
By Trading Economics
Revenu	2.7M 1.8M
Ventes	5.6M 172M
P/E Moyenne du Secteur	60.62 102.974
BPA	0.34
Marge bénéficiaire	1.048
Employés	3,771
EBITDA	4.6M 21M

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	-0.87 downside

Dividendes
By Dow Jones
Prochains Résultats	30 oct. 2024

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-10M 1.1B
Ouverture précédente	22.86
Clôture précédente	24.64

Sentiment de l'Actualité

By Acuity

26%

74%

55 / 366 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

23.72 / 24.28 Support & Résistance

Avanos Medical Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 sept. 2024, 23:50 UTC

Actions en Tendance

Stocks to Watch: Nike, FedEx, Alliance Entertainment Holding, Arq

19 sept. 2024, 20:59 UTC

Résultats

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q -- Update

19 sept. 2024, 20:41 UTC

Actualités

Nike CEO John Donahoe to Retire

19 sept. 2024, 20:40 UTC

Résultats

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q

19 sept. 2024, 23:24 UTC

Market Talk

Sims U.S. Business Shines, But Asia Headwinds Remain -- Market Talk

19 sept. 2024, 23:01 UTC

Actualités

U.K. Consumers Turn Notably Gloomier, Survey Says

19 sept. 2024, 22:21 UTC

Market Talk

Résultats

FedEx Warns of Continued, Worsening Headwinds in 2Q -- Market Talk

19 sept. 2024, 22:17 UTC

Actualités

Why Fed Rate Cuts Are Hurting Treasury Bonds -- Barrons.com

19 sept. 2024, 22:13 UTC

Market Talk

Résultats

FedEx Counts on Price Hikes to Help Hurting Top and Bottom Lines -- Market Talk

19 sept. 2024, 22:13 UTC

Market Talk

Résultats

Global Equities Roundup: Market Talk

19 sept. 2024, 22:06 UTC

Résultats

FedEx Stock Is Down. Earnings Show Why The Fed Cut Rates. -- Barrons.com

19 sept. 2024, 21:46 UTC

Actualités

Résultats

FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue -- Update

19 sept. 2024, 21:06 UTC

Résultats

FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com

19 sept. 2024, 20:50 UTC

Market Talk

Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

19 sept. 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19 sept. 2024, 20:50 UTC

Market Talk

Résultats

Auto & Transport Roundup: Market Talk

19 sept. 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19 sept. 2024, 20:42 UTC

Résultats

FedEx Stock Skids, Set To Snap Support As Q1 Results Disappoint -- IBD

19 sept. 2024, 20:39 UTC

Actualités

Dow, S&P 500 Hit Records After Rate Cut -- WSJ

19 sept. 2024, 20:12 UTC

Résultats

FedEx Unable to Provide FY25 EPS or Effective Tax Rate Outlook on GAAP Basis >FDX

19 sept. 2024, 20:12 UTC

Résultats

FedEx Cash On-Hand as of Aug 31 Was $5.9 B >FDX

19 sept. 2024, 20:11 UTC

Résultats

FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com

19 sept. 2024, 20:11 UTC

Résultats

FedEx: 'Committed to Our Plan to Return $3.8 B to Stockholders This Fiscal Yr' >FDX

19 sept. 2024, 20:11 UTC

Résultats

FedEx Expects Recent Pricing Actions to Help Offset Weaker-Than-Expected Demand Trends >FDX

19 sept. 2024, 20:10 UTC

Actualités

Dow Crosses 42000, Hits Record in Post-Fed Rally -- WSJ

19 sept. 2024, 20:10 UTC

Résultats

FedEx Reaffirms FY25 Capital Spending of $5.2 B >FDX

19 sept. 2024, 20:10 UTC

Résultats

FedEx Reaffirms Permanent Cost Reductions From DRIVE Transformation Program of $2.2 B >FDX

19 sept. 2024, 20:10 UTC

Résultats

FedEx Had Previously Forecast of Low-To-Mid Single Digit Percentage Increase in Rev for FY25>FDX

19 sept. 2024, 20:09 UTC

Résultats

FedEx Sees Low Single-Digit Percentage Rev Growth Rate Yr Over Yr for FY25>FDX

19 sept. 2024, 20:09 UTC

Résultats

FedEx Sees FY25 EPS $20 to $21 After Also Excluding Costs Related to Business Optimization Initiatives >FDX

Comparaison

Variation de prix

Avanos Medical Inc prévision

Objectif de Prix

By TipRanks

-0.87% baisse

Prévisions sur 12 Mois

Moyen 24 USD -0.87%

Haut 24 USD

Bas 24 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

Achat

Maintien

Vente

Basé sur 2 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

23.72 / 24.28Support & Résistance

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

55 / 366Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Avanos Medical Inc

Avanos Medical, Inc. is a medical technology company, which focused on delivering medical device solutions. The Company develops, manufactures and markets solutions in approximately 90 countries. It provides a portfolio of product offerings focused on chronic care and pain management to improve patient outcomes. Chronic care is a portfolio of products, which include digestive health products, such as its Mic-Key enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as its closed airway suction systems and other airway management devices under the Ballard, Microcuff and Endoclear brands. Pain management is a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and Interventional pain solutions, which provides pain relieving therapies, such as its Coolief pain therapy.